Visual Outcomes of SUPRACOR for presbyopia: 24-month follow-up

Session Details

Session Title: Refractive
Session Date/Time: Friday 21/02/2020 | 08:15-10:10
Paper Time: 09:36
Venue: Fes 1.

First Author: J.Sánchez-González SPAIN
Co Author(s): F. Alonso-Aliste  J. Amián-Cordero  C. Rocha-De-Lossada  M. Sánchez-González  C. De-Hita-Cantalejo  M. Hernández-Barahona  

Abstract Details

Purpose:

To analyze the efficacy, safety, predictability, and stability in hyperopic presbyopic laser in situ keratomileusis (LASIK) surgeries with the TENEO 317 algorithm (Bausch & Lomb Technolas, Munich, Germany).

Setting:

Private Refractive Surgery Center / Tecnolaser Clinic Vision

Methods:

Eighty eyes from 40 patients who underwent hyperopic and presbyopic LASIK in this retrospective, observational, and longitudinal study were included. All patients had a 24-month follow-up. Excimer laser treatment was performed with TECNOLAS Perfect Vision GmbH TENEO 317 software version 1.25 (Bausch & Lomb) with the PROSCAN platform for the distance dominant eye and the SUPRACOR mild platform for the near dominant eye.

Results:

Mean age was 53.90 ± 4.84 years (range: 42 to 66 years). Postoperative uncorrected distance visual acuity (UDVA) was 0.00 ± 0.04 (20/19.97) for the dominant eye and 0.14 ± 0.05 (20/27.65) for the non-dominant eye. Postoperative uncorrected near visual acuity was 0.51 ± 0.17 (J9) for the dominant eye and 0.09 ± 0.06 (J1.5) for the non-dominant eye, whereas 2.5% of non-dominant eyes lost two lines of corrected distance visual acuity. Half of non-dominant eyes lost one line, and 2.5% of dominant and non-dominant eyes changed 0.50 D or more between 3 and 24 months.

Conclusions:

PROSCAN surgery in the dominant eye and SUPRACOR surgery in the non-dominant eye using the TENEO 317 algorithm demonstrated that the hyperopic presbyopic excimer laser surgery technique resulted in acceptable and stable outcomes after 24 months of follow-up.

Financial Disclosure: